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Abstract 
Recent studies have suggested oxytocin’s therapeutic effects on deficits in social communication and 
interaction in autism spectrum disorder through improvement of emotion recognition with direct emotional 
cues, such as facial expression and voice prosody. Although difficulty in understanding of others’ social 
emotions and beliefs under conditions without direct emotional cues also plays an important role in autism 
spectrum disorder, no study has examined the potential effect of oxytocin on this difficulty. Here, we 
sequentially conducted both a case-control study and a clinical trial to investigate the potential effects of 
oxytocin on this difficulty at behavioural and neural levels measured using functional magnetic resonance 
imaging during a psychological task. This task was modified from Sally-Anne task, a well-known first-order 
false belief task. The task was optimised for investigation of the abilities to infer another person’s social 
emotions and beliefs distinctively, in order to test hypothesis that oxytocin improves deficit in inferring others’ 
social emotions rather than beliefs, under conditions without direct emotional cues. In the case-control study, 17 
men with autism spectrum disorder showed significant behavioural deficits in inferring others’ social emotions 
(P = 0.018) but not in inferring others’ beliefs (P = 0.064) compared with 17 typically developing 
demographically-matched male participants. They also showed significantly less activity in the right anterior 
insula and posterior superior temporal sulcus during inferring others’ social emotions, and in the dorsomedial 
prefrontal cortex during inferring others’ beliefs compared with the typically developing participants (P < 0.001 
& cluster size > 10 voxels). Then, to investigate potential effects of oxytocin on these behavioural and neural 
deficits, we conducted a double-blind placebo-controlled crossover within-subject trial for single-dose 
intranasal administration of 24 IU oxytocin in an independent group of 20 men with autism spectrum disorder. 
Behaviourally, oxytocin significantly increased the correct rate in inferring others’ social emotions (P = 0.043, 
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one-tail). At the neural level, the peptide significantly enhanced the originally-diminished brain activity in the 
right anterior insula during inferring others’ social emotions (P = 0.004), but not in the dorsomedial prefrontal 
cortex during inferring others’ beliefs (P = 0.858). The present findings suggest that oxytocin enhances the 
ability to understand others’ social emotions that have also required second-order false belief rather than 
first-order false beliefs under conditions without direct emotional cues in autism spectrum disorder at both the 
behaviour and neural levels. 
(385 words) 
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Introduction 
Autism spectrum disorder (ASD) is a developmental disorder that affects approximately 1% of the general 
population and has no established pharmacological treatment for its core symptoms (Centers for Disease 
Control and Prevention., 2012). The disorders are characterized by deficits in social communication and 
interaction, and repetitive and restricted behaviour (American Psychiatric Association, 2013). Among several 
cognitive components associated with these symptoms, inferring others’ emotions and beliefs is suggested to be 
one of the most important cognitive components whose disturbance is deeply related to deficits in social 
communication and social interaction of ASD (Frith, 2001). 
Inferring others’ emotions and beliefs is achieved even without direct emotional cues, such as emotional 
facial expressions or prosody (Gallagher et al., 2000; Shamay-Tsoory et al., 2007). Individuals with ASD have 
difficulty in inferring others’ emotions and beliefs under conditions without direct emotional cues as well as 
those with direct emotional cues (Castelli et al., 2002; Kana et al., 2006; Kaland et al., 2008; Masten et al., 
2011). It is supposed that individuals with ASD with high intelligence compensate for their difficulty with the 
ability to infer others’ beliefs (Shamay-Tsoory, 2008; Senju et al., 2009), but they still have deficits in the ability 
to infer others’ emotions (Baron-Cohen et al., 1997). As the ability of inferring others’ emotions without 
emotional cues is considered to play an important role in social relationships (Kidd and Castano. 2013), this 
disability is one potential reason that individuals with ASD show deficits in social communication and social 
interaction (van Riekel et al., 2010). 
Accumulating evidence supports the concept that oxytocin can induce effects on social and affiliative 
behaviours (Young and Wang, 2004; Jin et al., 2007; Guastella et al., 2008; Kim et al., 2010; Bartz et al., 2011; 
Guastella and MacLeod, 2012; Striepens et al., 2012). Although oxytocin may also promote aggression and 
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other antisocial behaviour in some circumstances (Miller, 2013), it is thought to be a potential therapeutic 
approach for deficits in social communication and interaction in individuals with ASD (Van IJzendoorn and 
Bakermans-Kranenburg, 2011; Yamasue et al., 2012; Bakermans-Kranenburg and Van IJzendoorn, 2013; 
Tachibana et al., 2013; Veening and Olivier, 2013). In fact, several previous studies have reported 
oxytocin-induced improvements of autistic behaviour (Hollander et al., 2003, 2007; Andari et al., 2010; 
Guastella et al., 2010; Anagnostou et al., 2012), and its neural basis (Domes et al., 2013a, 2013b; Gordon et al., 
2013; Watanabe et al., 2014). It should be noted that previous studies have repeatedly investigated and 
demonstrated oxytocin’s effectiveness in reducing difficulty in emotion recognition under conditions with 
direct emotional cues in individuals with ASD (Hollander et al., 2007; Guastella et al., 2010; Domes et al., 
2013b; Gordon et al., 2013; Watanabe et al., 2014). 
However, to the best of our knowledge, no studies have reported oxytocin’s effect on the abilities to infer 
others’ emotions and beliefs under conditions without direct emotional cues in individuals with ASD. There are 
many behavioural studies involving typically developing (TD) participants that reported that oxytocin improves 
recognition of emotion (Guastella and MacLeod, 2012; Shahrestani et al., 2013), and one study with TD 
participants showed oxytocin’s effect on inferring others’ emotions but not on inferring others’ beliefs 
(Hurlemann et al., 2010). Thus, we hypothesized that oxytocin may ease the deficit in inferring others’ 
emotions rather than beliefs in individuals with ASD and at least partially mitigate neural deficits of inferring 
others’ emotions rather than those of beliefs. 
To test our hypothesis, we conducted two experiments consisting of a case-control study and a clinical trial. 
For this purpose, we developed a psychological task by optimising the Sally-Anne task, a well-known task for 
test of first-order false beliefs, to investigate abilities to infer another person’s emotions and beliefs distinctively 
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under conditions without direct emotional cues. We used the task as is, to investigate neural correlates of 
difficulty in inferring others’ beliefs (Sommer et al., 2007). Additionally, we also investigated neural bases of 
deficit in inferring others’ emotions by adding a question at the end of the story using the same cartoon. The 
emotions in the present study are the social emotions that involve a two-person situation where one’s loss 
depends on another’s gain (Shamay-Tsoory et al., 2007) and include, for example, gloating when one 
successfully deceives another (Ortony et al., 1990; van Dijk et al., 2006). To correctly answer the question for 
social emotion conditions, an understanding of second-order false belief is also required. First, we conducted a 
functional MRI (fMRI) study to distinctively investigate neural correlates of these behavioural characteristics in 
individuals with ASD by comparing brain activity between individuals with ASD and TD. In the second 
experiment, we performed a double-blind, placebo-controlled, crossover trial for single-dose intranasal 
administration of oxytocin to investigate the behavioural and neural effect of the neuropeptide on deficits in 
inferring others’ social emotions and belief without direct emotional cues in individuals with ASD. 
 
Materials and methods 
Procedure 
The first experiment (Experiment 1) was a case-control fMRI study with a psychological task designed to study 
behavioural and neural deficits in inferring others’ social emotions and beliefs distinctively under conditions 
without direct emotional cues, which involved individuals with ASD and TD. In Experiment 1, we compared 
both behavioural performance and brain activity during the psychological task. To examine neural correlates for 
deficit in inferring others’ social emotions and beliefs, we explored brain regions where individuals with ASD 
show less brain activity during the psychological task compared with TD participants. 
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The second experiment (Experiment 2) was an fMRI study in a placebo-controlled double-blind crossover 
clinical trial where participants with ASD were intranasally administered a single-dose of oxytocin or placebo 
between an interval of 1 week. This experiment was performed with the same psychological task as 
Experiment 1 in totally different individuals in Experiment 1, to minimise habituation of the participants to the 
psychological task. In Experiment 2, we tested whether oxytocin improves the behavioural deficit shown in 
Experiment 1 and enhances the decreased brain activity during the task in brain regions identified in 
Experiment 1 in individuals with ASD, by comparing behavioural results and brain activity in the oxytocin 
session with those given placebo. 
 
Participants and diagnosis 
None of the individuals with ASD who participated in Experiment 1 were in Experiment 2. Experiment 2 
examined the main outcome of the clinical trial registered in the University Hospital Medical Information 
Network clinical trials registry (UMIN000004393). The participants in Experiment 2 were also participants of 
our study in a recent publication that reported a different outcome of the present clinical trial 
(UMIN000004393) in combination with another clinical trial (UMIN000002241) (Watanabe et al., 2014). The 
recruiting method and inclusion/exclusion criteria were the same as in our previous studies and a recent report 
of a different outcome of the present trial (Aoki et al., 2012; Watanabe et al., 2012, 2014). Briefly, among 323 
people with probable ASD who visited the outpatient services of The University of Tokyo hospital and Showa 
University Karasuyama Hospital, 40 high-functioning ASD males, who satisfied the eligibility criteria (firm 
diagnosis, age ≥20 years, full scale intelligence quotient (IQ) >80), were recruited. Seventeen individuals with 
ASD out of the 40 were assigned to Experiment 1 (29.6 ± 8.0 years old, mean ± SD)(Table 1) and 20 were 
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assigned to Experiment 2 (30.8 ± 6.0 y.o.)(Table 2), while the other 3 participants did not participate because of 
the schedule restriction (Fig. 1). The 17 individuals with ASD participated in Experiment 1 and 3 people who 
didn’t participate in the study are participants in another clinical trial (UMIN000002241) that was conducted at 
least 1 week apart from Experiment 1. Two individuals with ASD who participated in Experiment 1 were on 
antidepressants, while one was on antipsychotics in Experiment 2. Seventeen age-, IQ-, and parental 
socioeconomic status -matched TD adult males who served as controls in Experiment 1 were college students, 
graduate school students, hospital staff and their acquaintances (30.4 ± 5.6 y.o.)(Table 1) (Hollingshead, 1957). 
Handedness was determined using the Edinburgh Handedness Inventory (Oldfield, 1971), with a laterality 
index of >0.5 used as the cut-off for right-handedness. Participants whose laterality index score ranged from 
-0.5 to 0.5 were defined as mixed-handedness. The IQ of the TD group was estimated using a Japanese version 
of the National Adult Reading Test (NART) (Nelson, 1982; Matsuoka et al., 2006). Although the scores of the 
NART are well-correlated with the full scale IQ measured with Wechsler Adult Intelligence Scale Revised in 
TD individuals (Matsuoka et al., 2006), the application of the estimation of full scale IQ using the NART is 
problematic for individuals with ASD because of the well-known imbalances in their intellectual abilities. 
Therefore, the IQs of the ASD participants were assessed using the full scale of the Wechsler Adult Intelligence 
Scale Revised Japanese version (Wechsler, 1981). 
The exclusion criteria for both groups were: current or past neurological comorbidity, traumatic brain injury 
with any known cognitive consequences or loss of consciousness for more than 5 min, a history of 
electroconvulsive therapy and substance abuse or addiction. An additional exclusion criterion for the control 
group was a history of neuropsychiatric disorders in the participants themselves. 
The protocol for diagnoses in the current study was the same as our previous studies (Aoki et al., 2012; 
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Watanabe et al., 2012, 2014) that used the Diagnostic and Statistical Manual-Revision IV-Text Revision 
(American Psychiatric Association, 2000) in combination with the Japanese version of the Autism Diagnostic 
Interview-Revised (ADI-R) (Tsuchiya et al., 2012). The ASD diagnoses of seven individuals who did not meet 
the threshold in the ADI-R social domain were confirmed through an evaluation with the Autism Diagnostic 
Observation Schedule (Lord et al., 2000) by another certified psychologist (Miho Kuroda). All seven 
individuals were diagnosed with autism based on the Autism Diagnostic Observation Schedule social 
reciprocity + communication scores, Module 4, (15.2 ± 3.16, mean ±SD, range: 12−20, in which 10 is the 
minimum threshold for autism). In addition to the ADI-R that is mainly based on participants’ behaviour during 
their childhood, we also obtained the maternal-reported Social Responsiveness Scale (SRS) to measure 
participants’ behaviour at the time of experiments (Constantino, 2002). 
 
Interventions, randomisation, and masking in Experiment 2 
Description of interventions, randomisation, and masking is available elsewhere (Watanabe et al., 2014). 
Briefly, 40 min before scanning, the individuals with ASD received a single-dose oxytocin (24 IU; Syntocinon 
Spray, Novartis) intranasally (Kosfeld et al., 2005) or placebo, in a randomised fashion. Participants abstained 
from food and drink for 2 hr before the experiment, and from exercise, caffeine, and alcohol during the 24 hr 
before the session. No adverse side effects were observed. 
The randomisation and masking manager assigned each participant to an oxytocin-initially-administered or 
placebo-initially-administered group with a computer-generated randomised order. Individuals in an 
oxytocin-initially-administered group received placebo in the following scan 1 week later, and vice versa (Fig. 
1). Concretely, the individuals with ASD who had initially received placebo received oxytocin the following 
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week, while the other 10 individuals with ASD who had received oxytocin in the first session were 
administered placebo the following week. Thus, on the whole, the 20 individuals with ASD experienced both 
placebo and oxytocin sessions. The manager completely covered the label of the sprays to maintain the 
blindness of the participants and experimenters. 
 
MRI scanning 
In both experiments, participants were scanned in the same MR scanner with the same setting. A 3T MRI 
scanner (GE Signa HDxt,Waukesha, WI, USA) in The University of Tokyo Hospital was used. The anatomical 
scanning sequence was a three-dimensional Fourier-transform spoiled-gradient-recalled acquisition during 
steady state (TR = 6.8 s, slice thickness = 1 mm, in-plane resolution = 1 × 1 mm). A trained neuroradiologist 
(H.T./H.S./W.G.) found no gross abnormalities in any of the participants. Gradient-echo echo-planar sequences 
were used for functional imaging (TR = 3s, TE = 35 ms, FA = 80°, 4 × 4 × 4 mm3, 42 slices, ventral to dorsal 
interleaved acquisition). The first five functional images in each run were discarded to allow for equilibrium of 
longitudinal magnetisation. 
 
fMRI experimental procedure and paradigm  
This event-related fMRI experiment was performed using E-prime 2.1 (Pittsburgh, PA, USA). During a scan, 
participants underwent two runs consecutively. During one run, 10 different stories were presented to the 
participants (Supplementary Material). Each story was presented for three times consecutively and participants 
were required to answer one yes-no question at the end of each presentation. Thus, participants were demanded 
to answer 30 questions during one run. The same set of 10 stories was presented in both 1st and 2nd runs. But 
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questions whose answers are “yes” in the 1st run were modified to be questions whose answers are “no” in the 
2nd run, vice versa. The order of questions with “yes” and “no” was determined in a pseudo-random fashion. 
The scan time for each run was approximately 8 min. Each story consisted of four black and white comic 
frames based on Sally-Anne story and other stories that also require understanding of first-order false beliefs 
developed by Vollm et al., (Völlm et al., 2006). Before the scanning procedure, all the participants were shown 
the cartoon stories demonstrated in the scanner and required to answer to questions modified from the 
questions in the “Control” condition in the psychological task. By doing so, the participants were trained to 
understand the cartoon stories in order to complete the task appropriately without experiencing the questions of 
“Belief” and “Social emotion” condition in the task. 
Task conditions and trial timing are summarized in Figure 2A. Each trial consists of 1) 3.5 sec story 
presentation with four frames, 2) 2 sec of a frame with a question written in white on a black screen, 3) 2.5–3.5 
sec fixation cross, 4) 3 sec of a frame with comic vignette that illustrates an arrow and a star to help to answer 
the question, and 5) 3 sec fixation cross. Participants were required to answer this question during the last frame 
with comic and fixation cross (i.e. 4) & 5)), by pressing a button to answer yes or no. We measured the reaction 
time and correct rate during this psychological task. 
As summarised in Figure 2B, the four frames show a short story with two characters with neutral faces. In 
the story, one character (Sally) places a ball in a left box (Frame 1) and leaves the room (Frame 2). In her 
absence, another character (Anne) moves the ball to a right box (Frame 3) and then Sally returns (Frame 4) 
(Baron-Cohen et al., 1985; Senju et al., 2009). At the end of each presentation of the story, participants are 
asked the following three types of questions in a pseudo-random order: “Is actually the ball in this box? 
(indicating a left box with a star)” for control, “Does she look for her ball in this box? (indicating Sally with an 
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arrow and a left box by a star)” for belief inference, and “Does she feel playful, seeing the box opened?” for 
social emotion inference (Fig. 2C).  
To answer the first question, participants are required to understand the actual location of the ball. This 
condition was used as “Control”.  
For the second question, they are required to understand that Sally’s actions will be based on what she 
believes to be true, rather than the actual location. To answer the question, understanding of first-order false 
beliefs and knowing the actual location is necessary. This condition that requires one to infer others’ false 
beliefs was named as “Belief”.  
With regard to the third question, participants were required to answer the question about Anne’s emotional 
status after she completed the practical joke. To rationally imagine the emotional status of the character, it is 
required to understand the situation correctly, i.e. that Anne believes that Sally falsely believes the ball is in the 
left box, but actually the ball is in the right box. Thus, to answer the question correctly, understanding of the 
second-order false belief (Shamay-Tsoory et al., 2009), the first-order false belief, and the actual location of the 
ball itself, are necessary and the ability to infer Anne’s emotion. This condition was named “Social emotion” 
(Völlm et al., 2006) (Fig. 2C).  
In this context, as we recognised that the “Belief” condition requires the ability to infer others’ beliefs and 
understanding of the actual location, which is required to answer “Control” condition, the difference between 
“Belief” and “Control” conditions represents the ability to infer others’ false beliefs; thus we named the brain 
activity of the contrast as “belief minus control activity”. Similarly, we also recognised that the “Social emotion” 
condition requires the ability to infer others’ social emotions and false beliefs without direct emotional cues in 
addition to understanding the actual location. In other words, “Social emotion” condition comprises both 
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cognitive components to infer others’ emotion without direct emotional cues and to answer “Belief” condition. 
Thus, we took difference between “Social emotion” and “Belief” conditions to represent inferring others’ social 
emotions without direct emotional cues and named the brain activity of the contrast as “social minus belief 
activity”. 
  
Behavioural analysis 
For Experiment 1, to investigate whether individuals with ASD have a behavioural deficit in inferring others’ 
social emotions and beliefs under conditions without direct emotional cues, we performed independent t-tests 
to compare reaction time and correct rate of the psychological task between individuals with ASD and TD. As 
we predicted that individuals with ASD have a deficit in inferring others’ social emotions, thresholds for 
statistical significance of reaction time and correct rate of Social emotion condition were set at one-tailed P < 
0.025 (=0.05/2, number of behavioural variables in Social emotion condition). On the other hand, as we have 
not assumed a behavioural deficit in high-functioning individuals with ASD in inferring others’ first-order false 
beliefs and understanding the story (Shamay-Tsoory, 2008; Senju et al., 2009), we set the threshold of statistical 
significance of reaction time and correct rate in Belief and Control conditions set at P < 0.0125 (=0.05/4, 
number of behavioural variables of two conditions). 
For Experiment 2, a paired t-test was conducted to test whether oxytocin, compared with placebo, mitigates 
behavioural performance where individuals with ASD showed significant deficit in Experiment 1 compared 
with TD participants (i.e. low correct rate for Social emotion, see Results). Statistical significance was set at 
one-tailed P < 0.05. 
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fMRI analysis 
The fMRI data were analysed with SPM8 (http://www.fil.ion.ucl.ac.uk/spm/). Functional images were 
realigned, slice timing corrected, normalised to the default template with interpolation to a 2 × 2 × 2 mm3 space, 
and smoothed (full width half maximum = 8 mm, Gaussian filter). To remove low-frequency drift from the 
data, high-pass temporal filtering with a cut-off of 128 s was applied. Independent t-tests have showed there 
was no significant difference in the extent of motion (x/y/z/pitch/yaw/roll) between individuals with ASD and 
TD in Experiment 1. Repeated measure ANOVA has demonstrated that there was also no significant difference 
in it between the oxytocin and placebo sessions in individuals with ASD in Experiment 2. 
At a single-subject level, we used a general linear model with three regressors (Social emotion, Belief, and 
Control). Each event-related regressor had an onset at the time of presentation of question and a duration that 
corresponded to each response time. Two contrast images of interest were estimated for each participant: (i) 
social minus belief activity and (ii) belief minus control activity. Only brain activities during the event with 
correctly answered questions were analysed. 
In the second-level analysis for Experiment 1, the resulting contrast images were entered into separate 
group-level analyses for each contrast of interest, in which one-sample t-tests were performed. For the 
interaction analysis between social minus belief and belief minus control activities by group (TD vs. ASD), a 
statistical threshold was set at P < 0.001, whole brain analysis, uncorrected for multiple comparisons with 
minimum cluster extent 10 voxels, based on recent fMRI studies with similar sample sizes (Hsu et al., 2008; 
Harding et al., 2012; Wymbs et al., 2012; Politis et al., 2013). The analyses identified brain regions where 
individuals with ASD showed significantly less brain activity compared with TD participants. The detected 
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brain regions were used to determine regions-of-interest (ROI) in Experiment 2. 
Then, for Experiment 2, to assess the enhancement effect of oxytocin on originally-less-than-TD brain 
activity in Experiment 1, we conducted an ROI analysis by performing paired t-tests of two contrasts (social 
minus belief activity and belief minus control activity) separately in individuals with ASD between oxytocin 
and placebo sessions. The ROIs were defined as spheres with radii of 4 mm around the peak coordinate, 
identified in Experiment 1 as the centres (Table 3). Averaged BOLD signal in these ROIs in oxytocin and 
placebo sessions were extracted, and paired t-tests were conducted to assess the effect of oxytocin on brain 
activity. As we have a priori hypothesis that oxytocin administration may increase originally-diminished social 
minus belief activity, statistical significance was set at one-tailed P < 0.025 (= 0.05/2, Bonferroni-corrected for 
two ROIs, see Results) for social minus belief activity. With regard to belief minus control activity, we adopted 
a statistical threshold at P < 0.05. 
To additionally explore the global trend of oxytocin’s effect on brain activity, we also conducted a 
voxel-wise whole-brain search for brain regions that showed significant increases induced by oxytocin in social 
minus belief activity compared with placebo, adopting a relatively liberal threshold (whole brain P < 0.002, 
uncorrected, minimum cluster extent 10 (Rossion et al., 2003)). 
 
Correlation between behavioural result and clinical indices 
In Experiment 1, we calculated Pearson’s correlation coefficients between the task performance impaired in 
ASD and the SRS in individuals with ASD. A statistical threshold was set at P < 0.05. On the other hand, to 
explore the influence of potential confounds, we also performed Pearson’s correlation analyses between task 
performance, where individuals with ASD showed significant deficit, and age, IQ and parental socioeconomic 
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status in individuals with ASD. We also adopted a threshold for statistical significance with correction of 
multiple comparisons at P < 0.017 (=0.05/3, number of potential confounds). 
Likewise for the behavioural results, we assessed a potential association between averaged BOLD signals 
in the ROIs where individuals with ASD showed significantly decreased social minus belief-/belief minus 
control activity compared with TD participants, and clinical information of interest, such as the SRS score. A 
statistical threshold was set at P < 0.05. Additionally, potential associations between averaged BOLD signals in 
the ROIs identified in Experiment 1 and potential confounds, such as age, IQ, and parental socioeconomic 
status were also assessed. A statistical threshold was set at P < 0.017 (=0.05/3, number of potential confounds). 
 
Correlation between oxytocin-induced changes in brain activities and those in behaviour during 
the task 
In Experiment 2, to test potential association between oxytocin induced brain activity enhancement and 
oxytocin-induced change of behaviour, we calculated relation between oxytocin induced averaged BOLD 
signal changes in ROIs and oxytocin-induced behavioural changes of the corresponding condition (e.g. social 
minus belief activity and correct rate for Social emotion condition). As there was significant effect of oxytocin 
only on the correct rate of Social emotion condition, the significance level was set at P < 0.05 (see Results 
section). 
 
Evaluation of effect of recruiting different groups of individuals with ASD in identifying the 
ROIs in Experiment 1 and examining the effect of oxytocin in Experiment 2 
We recognise it beneficial to recruit independent groups between the case-control and clinical trials. Because 
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participants in Experiment 2 did not experience the psychological task before, the effect of habituation to the 
task is supposed to be minimised. However, one potential drawback of this method is that ROIs identified by 
different groups of individuals with ASD in the Experiment 1 may not be the brain region where individuals 
with ASD in Experiment 2 to whom oxytocin was actually administered would show less-than-TD brain 
activity. Thus, there may not be the effect of oxytocin on the brain regions identified with individuals with ASD 
in Experiment 2. To test whether the statistical conclusion is preserved after controlling the effect of differences 
in groups of individuals with ASD between Experiment 1 and Experiment 2, we compared contrast images of 
social minus belief activity of 20 individuals with ASD in the placebo session of Experiment 2 with those in 17 
TD participants in Experiment 1. To identify the ROI where individuals with ASD in the placebo session of 
Experiment 2 showed less brain activity, a statistical threshold was set at P < 0.001, whole brain analysis, 
uncorrected for multiple comparisons with minimum cluster extent 10. Then, paired t-tests were conducted to 
test the effect of oxytocin on brain activity in the ROI identified in this comparison. As this is a confirmatory 
analysis, we set the same threshold for statistical significance at P < 0.025, as the threshold for the right anterior 
insula (AI) in Experiment 2.  
 
Excluding the effect of psychotropic medication on identifying ROIs and the effect of oxytocin 
Furthermore, to examine the potential effect of psychotropic medication, we repeated the series of analyses by 
excluding individuals with ASD on psychotropic medication, i.e. two individuals with ASD from Experiment 1 
and one from Experiment 2. 
 
Comparison of the behavioural results of Experiments 1 and 2 
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To characterise the effect of oxytocin on behaviour as an exploratory step, we have compared results of 
Experiments 1 and 2. First, we conducted an independent t-test to compare the correct rate of Social emotion in 
individuals with ASD after oxytocin administration in Experiment 2 with those in TD participants as well as in 
individuals with ASD in Experiment 1. Then, the correct rate of Social emotion in individuals with ASD on 
placebo session in Experiment 2 was compared with those in ASD participants in Experiment 1. Statistical 
thresholds for these analyses were set at P < 0.05. 
 
Results 
Experiment 1 (ASD vs. TD) 
Behavioural data 
Independent t-tests revealed that the correct rate among individuals with ASD was significantly lower than that 
among TD participants in the Social emotion condition (t(32) = 2.50, Cohen’s d = 0.80, P = 0.009, one-tailed) 
(Fig. 3A), but there was no significant difference in the correct rate in Belief (t(32) = 1.92, d = 0.63, P = 0.064) 
and Control conditions (t(32) = 1.04, d = 0.36, P = 0.307) (Fig. 3A). With regard to the reaction time, there was 
no significant difference between individuals with ASD and TD in Social emotion (t(32) = 1.28, d = 0.44, P = 
0.104, one-tailed), Belief (t(32) = 2.03, d = 0.67, P = 0.051) and Control conditions (t(32) = 1.04, d = 0.54, P = 
0.307) (Fig. 3B). 
 
fMRI analysis 
Social minus belief activity 
We identified brain regions where individuals with ASD showed significantly less social minus belief brain 
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activity compared with TD participants. As illustrated in Figure 3, the whole brain analysis demonstrated less 
social minus belief activity in the right AI ([x, y, z]=[48, 20, –14] (Montreal Neurological Institute coordinates), 
k = 17; t(32) = 3.91; P < 0.001 uncorrected) (Fig. 3A, Table 3) and the right posterior superior temporal sulcus 
(STS) ([56, –64, 36], k = 19; t(32) = 3.78; P < 0.001 uncorrected) (Fig. 3B, Table 3).  
 
Belief minus control activity 
We further examined brain regions where individuals with ASD showed significantly less brain activity 
compared with TD participants during “Belief” relative to “Control” conditions. As illustrated in Figure 3, 
whole brain analysis demonstrated significantly less belief minus control activity in the dorsomedial prefrontal 
cortex (dmPFC) ([0,18,20], k = 21; t(32) = 3.78; P < 0.001 uncorrected) (Fig. 3C).  
 
Correlation between the behavioural result and clinical indices 
In Experiment 1, Pearson’s correlation analyses demonstrated that the SRS was negatively correlated with the 
correct rate of Social emotion (r = -0.675, P = 0.004) across individuals with ASD, whereas the ADI-R scores 
were not correlated with the correct rate in Social emotion (P > 0.405). On the other hand, there was no 
significant association between the correct rate of Social emotion and potential confounds, such as age, parental 
SES and full scale IQ (P > 0.439). 
With regard to belief minus control activity, although averaged BOLD signals in the dmPFC showed 
correlation with the SRS (P = 0.029) and ADI-R reciprocal social interaction scores (P = 0.036), the 
significances disappeared after correcting multiple comparison (P > 0.062). There was no significant 
correlation between averaged BOLD signals in three brain regions where individuals with ASD showed 
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significantly lower-than-TD activity and potential confounds (P > 0.158). 
 
Experiment 2 (Oxytocin vs. Placebo in individuals with ASD) 
Oxytocin’s effects on behaviour 
As Experiment 1 showed a significantly lower correct rate in Social emotion condition among individuals with 
ASD compared with TD participants, the purpose in Experiment 2 was to test whether oxytocin increases the 
basically low correct rate in individuals with ASD. Paired t-test demonstrated that oxytocin significantly 
increased the correct rate of Social emotion in individuals with ASD compared with placebo (t(19) = 1.81, r2 = 
0.15, P = 0.043, one-tailed). As the analysis has shown a trend level difference in the correct rate of Belief 
condition, we have additionally investigated the potential effect of oxytocin on the correct rate. Paired t-test has 
shown that there was no significant difference in the correct rate of Belief between oxytocin and placebo 
sessions (t(19) = 0.948, r2 = 0.045, P = 0.355). 
 
Oxytocin’s effects on social minus belief activity in the right AI  
We then investigated whether oxytocin increased the originally-less-than-TD brain activity in individuals with 
ASD in Experiment 1, by conducting paired t-tests to compare brain activities at the oxytocin session with 
those at the placebo session. For the social minus belief activity contrast, the analysis demonstrated that 
oxytocin significantly increased brain activity in the right AI (t(19) = 3.00, r2 = 0.32, P = 0.004, one-tailed) (Fig. 
4B, Table 4). On the other hand, there were no significant effects of oxytocin on brain activity in the right 
posterior STS (t(19) = 1.50, P = 0.075, one-tailed) (Fig. 4B, Table 4). With regard to ROIs where individuals 
with ASD showed significantly less belief minus control activity in Experiment 1, there were no significant 
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effects of oxytocin on brain activity in the dmPFC (t(19) = 0.18, r2 < 0.01, P = 0.858) (Fig. 4C, Table 4). 
 
Results of voxel-wise whole-brain analysis 
To ensure global specificity of the effects of oxytocin, we also conducted a whole-brain analysis. Significant 
activities were found in the cuneus ([4,-86,40], k = 47; t(19) = 4.36; P < 0.001 uncorrected), the right anterior 
middle temporal gyrus ([60,0,-22], k = 19; t(19) = 3.85; P = 0.001 uncorrected), the right inferior frontal gyrus 
([60,18,-2], k = 39; t(19) = 3.60; P = 0.001 uncorrected) and the right AI ([46,24,-18], k = 17; t(19) = 3.57; P = 
0.001 uncorrected) in the oxytocin session compared with the placebo session in social minus belief activity. 
Analysis showed that oxytocin induced an enhancement of social minus belief activity in the brain region that 
covers the right AI, which partially overlapped with the right AI ROI defined from the results of Experiment 1 
(Fig. 4D). 
 
Relationship between oxytocin-induced increase of the right AI brain activity and behavioural change 
There was no significant relationship between oxytocin-induced changes in social minus belief activity in the 
right AI and those in the correct rate of Social emotion (r = 0.138, P = 0.561). 
 
Evaluation of effect of recruiting different groups of individuals with ASD in identifying the ROIs and 
examining the effect of oxytocin 
The individuals with ASD in the placebo session of Experiment 2 showed significantly less social minus belief 
brain activity in the right AI compared TD participants in Experiment 1 ([50,18,-12], k = 54; t(35) = 4.13; P < 
0.001 uncorrected, whole brain analysis), which includes the peak coordinate identified in Experiment 1 
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([48,20,-14]), in social minus belief activity contrast in this comparison (Supplementary Fig. 1A). Furthermore, 
a paired t-test that compared brain activity of 4 mm radii of the peak coordinate identified by the comparison 
between individuals with ASD at the placebo session and TD participants showed a significant increase of the 
originally-diminished brain activity in the oxytocin session compared with placebo (t(19) = 2.716, r2 = 0.28, P 
= 0.007, one-tailed) (Supplementary Fig. 1A). 
 
Excluding the effect of psychotropic medication on identifying ROIs and effect of oxytocin 
The series of analyses excluding 3 out of the 37 individuals with ASD on psychotropic medication 
demonstrated significantly less social minus belief activity in the right AI ([48,20,-14], k = 11; t(30) = 3.34; P < 
0.001 uncorrected, whole brain analysis) in individuals with ASD compared with TD (Supplementary Fig. 1C), 
and oxytocin induced statistically significant enhancement of social minus belief activity in the brain region 
(t(18) = 3.11, r2 = 0.35, P = 0.003, one-tailed), indicating that the statistical conclusions are free from the effect 
of psychotropic medication (Supplementary Fig. 1D). 
 
Comparison of the behavioural results of Experiments 1 and 2 
The analysis showed that there was no significant difference between the correct rate of Social emotion in 
individuals with ASD after oxytocin administration in Experiment 2 (83.5 ± 17.0%) and those found in TD 
participants in Experiment 1 (84.1 ± 13.0%) (t(35) = 0.12, P = 0.90). On the other hand, the correct rate of 
Social emotion in individuals with ASD after oxytocin administration was significantly higher than the correct 
rate of Social emotion among individuals with ASD in Experiment 1 (70.0 ± 19.7%) (t(35) = 2.26, P = 0.03). 
Furthermore, it is shown that there was no significant difference in the correct rate of Social emotion between 
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individuals with ASD in Experiment 1 and those in the placebo session in Experiment 2 (t(35) = 1.28, P = 
0.21). 
 
Discussion  
The crucial finding of the present study is that intranasal administration of oxytocin enabled high-functioning 
individuals with ASD to recover their behavioural and neural deficits in their ability to infer others’ social 
emotions under conditions without direct emotional cues. We first demonstrated that individuals with ASD 
have behavioural difficulties, such as low accuracy in inferring others’ social emotions without direct emotional 
cues compared with matched TD participants in Experiment 1. Experiment 1 also demonstrated that the 
individuals with ASD showed lower activities in the right AI and STS while inferring others’ social emotions, 
and in the dmPFC while inferring beliefs, compared with TD participants. Then, in Experiment 2, we found 
that oxytocin behaviourally improved accuracy in inferring others’ social emotions without direct emotional 
cues. At the neural level, Experiment 2 further showed that oxytocin enhanced the originally-diminished social 
minus belief activity in the right AI in individuals with ASD, but such effect was not observed in the belief 
minus control activity.  
Although individuals with ASD showed significantly lower correct rate in the Social emotion condition 
than individuals with TD, their correct rate was much higher than 50%, a random choice, suggesting that it is 
unlikely that individuals with ASD did not understand the psychological task accurately. In addition, the 
participants stated that they understood that they were expected to imagine the emotion of the protagonist in the 
cartoon stories, based on a situation in which one deceived the other. It should be noted that the current findings 
cannot be directly extended to female individuals with ASD, or ASD individuals with intellectual disability. 
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Furthermore, we did not administer oxytocin in TD individuals. Because the ability to infer others’ social 
emotions is not impaired in individuals with TD, the administration of oxytocin to individuals with TD is 
outside the aims of the present study, which examines the potential of oxytocin in treating this deficit. Thus, it 
remains unknown whether oxytocin’s effects are specific to individuals with ASD. 
The present result, suggesting that the AI is a neural correlate of the deficits in inferring others’ social 
emotions without direct emotional cues, is concordant with the results from previous studies that demonstrated 
involvement of the AI in disturbed processing of others’ social emotions, such as empathy, and also inferring 
others’ social emotions in individuals with ASD (Bird et al., 2010; Schulte-Rüther et al., 2013). 
The present study showed less-than-TD social minus belief activity in the STS, whose peak coordinate is 
[56, -65, 36], in individuals with ASD. The peak coordinate is close to the posterior STS [59, -44, 17] reported 
by Pelphrey et al., which is also known as a neural basis of the deficit in inferring others’ beliefs in individuals 
with ASD (Pelphrey et al., 2007, 2011; Pelphrey and Carter, 2008). On the other hand, the peak coordinate is 
also close to the temporoparietal junction [57, -57, 18] reported by Saxe et al., which is supposed to be involved 
in the false belief task (Saxe et al., 2006). In the present study, the Social emotion condition also demands 
understanding of a higher order of false belief than the Belief condition (second-order vs. first-order). Thus, the 
less brain activity in this brain region in the social minus belief activity contrast may represent a stronger 
burden of understanding of false belief (Happe, 1994; Singer, 2006). 
It has been repeatedly reported that the dmPFC is one of the potential neural bases in individuals with ASD 
for disturbed social cognition, such as inferring others’ beliefs (Redcay et al., 2013; Bernhardt et al., 2013). 
Thus, it is expected that the present study has successfully detected a neural basis of deficit in inferring others’ 
belief in individuals with ASD. 
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It should be noted that the task in the present study does not provide direct emotional cues, in contrast to 
previous studies with individuals with ASD that demonstrated oxytocin’s effect on recognition of emotion 
under conditions with direct emotional cues, such as facial or prosodic expression (Hollander et al., 2007; 
Guastella et al., 2010; Domes et al., 2013b). Additionally, the emotion in the present study is gloating when one 
successfully deceives another, which is a social rather than basic emotion (Ortony et al., 1990; van Dijk et al., 
2006) and involves a two-person situation in which one’s loss depends on another’s gain (Shamay-Tsoory et al., 
2007). The present study extends oxytocin’s effects on recognition of emotions to a deficit in inferring social 
emotions of others under conditions without direct emotional cues in individuals with ASD. 
The present study showed that oxytocin enhances originally-diminished social minus belief activity in the 
right AI of ASD participants. The limbic/paralimbic structures are supposed be one of the brain regions where 
oxytocin has an influence (Ferguson et al., 2001; Inoue et al., 2010; Insel, 2010; Meyer-Lindenberg et al., 
2011; Tost et al., 2011; Yamasue et al., 2011). In line with this notion, previous studies with TD participants 
have repeatedly demonstrated that oxytocin administration enhances AI activity and its functional connectivity 
with other limbic/paralimbic structures underlying enhancement of social behaviour (Baumgartner et al., 2008; 
Singer et al., 2008; Riem et al., 2011; Rilling et al., 2012; Striepens et al., 2012; Wittfoth-Schardt et al., 2012). 
One study with TD individuals reported that the peripheral level of oxytocin has also been reported to be 
associated with AI activity (Strathearn et al., 2009). Additionally, our recent study reported that individuals 
having smaller right AI volume show low prosociality and higher frequency in a common allele in the oxytocin 
receptor gene rs2254298A (Saito et al., 2013), a risk allele for ASD in the Asian population (Yamasue, 2013). 
Together with these studies, the current results further support the finding that the AI is one of several potential 
target regions where oxytocin acts. 
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The results of the present study suggest that less-than-TD brain activity in the right AI is a potential neural 
basis of deficit in inferring others’ social emotions without direct emotional cues in individuals with ASD. A 
single-dose of intranasal administration of oxytocin may improve the behavioural deficit in inferring others’ 
social emotions under conditions without direct emotional cues, and enhance the originally-diminished right AI 
activity in individuals with ASD. These results potentially extend the potential usage of oxytocin to autistic 
deficits in inferring others’ social emotions without direct emotional cues both at the behavioural and neural 
levels. 
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Figure legends 
Figure 1  
 
 
Participant recruitment. Among 323 people with probable ASD, 40 individuals with ASD were recruited. 
Among them, 17 individuals with ASD were assigned to Experiment 1 and another 20 were assigned to 
Experiment 2. Three individuals with ASD did not participate because of a schedule conflict. Among 20 
individuals with ASD enrolled in Experiment 2, 10 individuals with ASD were assigned to an 
oxytocin-initially-administered group, whereas the other 10 individuals with ASD were assigned to a 
placebo-initially-administered group. Individuals in both groups received both oxytocin and placebo with an 
interval of 1 week.  
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323 assessed for eligibility 
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Figure 2  
 
Task design. A) The figure summarises the task design with one of ten stories. 1) Each story includes four 
frames of a black and white comic (3.5 sec). 2) Then, a frame with a question written in white letters on the 
black screen was shown (2 sec). 3) After 2.5–3.5 sec white fixation cross on the black screen, 4) another frame 
was presented to illustrate an arrow and a star to help to answer the question (3 sec). At the end of one story, 5) 
a 3 sec fixation cross was shown. During the last frame and fixation cross, participants were instructed to 
answer the question with yes or no. B) Each story consisted of four frames with two people. There are ten 
different types of stories that require understanding of first-order false beliefs. C) Each story was presented 
three times consecutively per each run. At the end of the story presentation, participants were asked to answer 
the following three types of questions that asked emotion of the character, belief of the character, and fact. 
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These three questions appear in a pseudo-random order. Each time, an appropriate comic frame follows after 
the fixation cross. 
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Figure 3  
 
Behaviour and fMRI results in Experiment 1. (ASD vs TD). A) Effect of ASD diagnosis on correct rate for 
Social emotion, Belief, and Control conditions. ** TD participants demonstrated significantly higher correct 
rate of Social emotion condition compared with individuals with ASD (P = 0.009); bar: s.e.. B) Effect of 
diagnosis on reaction time for Social emotion, Belief, and Control conditions. C) Two panels show the brain 
regions where individuals with ASD showed less brain activity compared with TD participants in social minus 
belief brain contrast (P < 0.001 uncorrected) (AI: anterior insula, STS: superior temporal sulcus). Brain regions 
used in analyses reported in the subpanels B and C were determined from the results of Experiment 1. D) Panel 
shows the brain regions where individuals with ASD showed less brain activity compared with TD participants 
in belief minus control brain contrast (P < 0.001 uncorrected) (dmPFC: dorsomedial prefrontal cortex).   
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Figure 4   
 
Behavioural and fMRI results of Experiment 2. randomised trial. A) *Individuals with ASD showed 
significantly higher correct rate in Social emotion condition in the oxytocin session compared with the placebo 
session (P = 0.043); bar: s.e.. B) Percent signal changes in oxytocin and placebo sessions in brain regions where 
individuals with ASD showed basically less brain activity in social minus belief contrast. C) Percent signal 
changes in oxytocin and placebo sessions in brain regions where individuals with ASD showed less brain 
activity in belief minus control contrast. **Oxytocin significantly improved brain activity of the right AI in 
individuals with ASD (P = 0.004, one-tailed). D) Result of a voxel-wise whole-brain search for brain regions 
that showed an increase in social minus belief activity in the oxytocin session compared with the placebo 
session in the right anterior insula (P < 0.002, whole brain uncorrected). The location where oxytocin activated 
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partially overlapped with the region of interest defined based on ASD-TD comparison in Experiment 1 (red 
circle). 
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Supplementary Figure 1   
 
fMRI results of supplementary analyses to explore replicability of social minus belief activity in the right 
anterior insula and oxytocin’s effect on it. A) This panel shows the brain region where individuals with ASD in 
the placebo session of Experiment 2 showed less brain activity compared with TD participants in Experiment 1 
in social minus belief brain contrast (P < 0.001 uncorrected) (AI: anterior insula). B) Percent signal changes of 
the sphere of 4 mm radii from the peak coordinate shown in panel A) in oxytocin and placebo sessions in brain 
regions where individuals with ASD in the placebo session of Experiment 2 showed less brain activity in social 
minus belief contrast. **Oxytocin significantly improved brain activity of the right AI in individuals with ASD 
(P = 0.007); bar: s.e.. C) This panel shows the brain region where individuals with ASD without psychotropic 
medication in Experiment 1 showed less brain activity compared with TD participants in Experiment 1 in 
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social minus belief brain contrast (P < 0.001 uncorrected) (AI: anterior insula). D) Percent signal changes in the 
sphere of 4 mm radii from the peak coordinate shown in panel C) in oxytocin and placebo sessions in brain 
regions where individuals with ASD without medication showed less brain activity in social minus belief 
contrast. **Oxytocin significantly improved brain activity of the right AI in individuals with ASD (P = 0.003); 
bar: s.e.. 
 
Supplementary Material  Supplementary material shows ten different types of story with four black and 
white comic frames presented during the scan. They are based on Sally-Anne story and modified from stories 
that also require understanding of first-order false beliefs developed by Vollm et al., (Völlm et al., 2006). Four 
frames were presented for the same rate and interval. Ten stories appeared in a pseudo-random fashion. “S”s 
and “E”s stand for “start” and “end” of the story in this supplementary material. 
 
Funding 
A part of this study is a result of the “Development of biomarker candidates for social behavior” project under 
the Strategic Research Program for Brain Sciences by the MEXT. We acknowledge the supports provided by 
KAKENHI (22689034 to H.Y.; 20591378 to N.Y.), the Global Centre of Excellence Program (N.Y.), and a 
grant from the Japan Society for the Promotion of Science Research Foundation for Young Scientists (222882 
to T.W). 
 35 
References 
Anagnostou E, Soorya L, Chaplin W, Bartz J, Halpern D, Wasserman S, et al. Intranasal oxytocin versus 
placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial. 
Mol Autism. 2012; 3: 16. 
Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A. Promoting social behavior with oxytocin in 
high-functioning autism spectrum disorders. Proc Natl Acad Sci USA. 2010; 107: 4389-94. 
Aoki Y, Abe O, Yahata N, Kuwabara H, Natsubori T, Iwashiro N, et al. Absence of age-related prefrontal NAA 
change in adults with autism spectrum disorders. Transl Psychiatry. 2012; 2: e178. 
American Pychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th ed. Washington 
DC: American Psychiatric Association; 2000. 
American Pychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition: 
American Psychiatric Publishing; 2013. 
Bakermans-Kranenburg MJ, van IJMH. Sniffing around oxytocin: review and meta-analyses of trials in healthy 
and clinical groups with implications for pharmacotherapy. Transl Psychiatry. 2013; 3: e258. 
Baron-Cohen S, Jolliffe T, Mortimore C, Robertson M. Another advanced test of theory of mind: evidence 
from very high functioning adults with autism or asperger syndrome. J Child Psychol Psychiatry. 
1997; 38: 813-22. 
Baron-Cohen S, Leslie AM, Frith U. Does the autistic child have a “theory of mind” ? Cognition. 1985; 21: 
37-46. 
Bartz JA, Zaki J, Bolger N, Ochsner KN. Social effects of oxytocin in humans: context and person matter. 
Trends Cogn Sci. 2011; 15: 301-9. 
 36 
Baumgartner T, Heinrichs M, Vonlanthen A, Fischbacher U, Fehr E. Oxytocin shapes the neural circuitry of 
trust and trust adaptation in humans. Neuron. 2008; 58: 639-50. 
Bernhardt BC, Valk SL, Silani G, Bird G, Frith U, Singer T. Selective disruption of sociocognitive structural 
brain networks in autism and alexithymia. Cereb Cortex. 2013 online publication. 
Bird G, Silani G, Brindley R, White S, Frith U, Singer T. Empathic brain responses in insula are modulated by 
levels of alexithymia but not autism. Brain. 2010; 133: 1515-25. 
Castelli F, Frith C, Happe F, Frith U. Autism, Asperger syndrome and brain mechanisms for the attribution of 
mental states to animated shapes. Brain. 2002; 125: 1839-49. 
Constantino JN. The Social Responsiveness Scale. Los Angeles: Western Psychological Services; 2002 
Domes G, Heinrichs M, Kumbier E, Grossmann A, Hauenstein K, Herpertz SC. Effects of intranasal oxytocin 
on the neural basis of face processing in autism spectrum disorder. Biol Psychiatry. 2013a; 74: 
164-71. 
Domes G, Kumbier E, Heinrichs M, Herpertz SC. Oxytocin promotes facial emotion recognition and 
amygdala reactivity in adults with Asperger syndrome. Neuropsychopharmacology. 2013b; 39: 
698-706. 
Ferguson J, Aldag J, Insel T, Young L. Oxytocin in the medial amygdala is essential for social recognition in the 
mouse. J Neurosci 2001; 21: 8278-85. 
Frith U. Mind blindness and the brain in autism. Neuron. 2001; 32: 969-79. 
Gallagher H, Happé F, Brunswick N, Fletcher P, Frith U, Frith C. Reading the mind in cartoons and stories: an 
fMRI study of 'theory of mind' in verbal and nonverbal tasks. Neuropsychologia. 2000; 38: 11-21. 
Gordon I, Vander Wyk BC, Bennett RH, Cordeaux C, Lucas MV, Eilbott JA, et al. Oxytocin enhances brain 
 37 
function in children with autism. Proc Natl Acad Sci USA 2013; 110: 20953-8. 
Guastella A, MacLeod C. A critical review of the influence of oxytocin nasal spray on social cognition in 
humans: evidence and future directions. Horm Behav. 2012; 61: 410-8. 
Guastella AJ, Einfeld SL, Gray KM, Rinehart NJ, Tonge BJ, Lambert TJ, et al. Intranasal oxytocin improves 
emotion recognition for youth with autism spectrum disorders. Biol Psychiatry. 2010; 67: 692-4. 
Guastella AJ, Mitchell PB, Dadds MR. Oxytocin increases gaze to the eye region of human faces. Biol 
Psychiatry. 2008; 63: 3-5. 
Happe FG. An advanced test of theory of mind: understanding of story characters' thoughts and feelings by able 
autistic, mentally handicapped, and normal children and adults. J Autism Dev Disord. 1994; 24: 
129-54. 
Harding IH, Solowij N, Harrison BJ, Takagi M, Lorenzetti V, Lubman DI, et al. Functional connectivity in 
brain networks underlying cognitive control in chronic cannabis users. Neuropsychopharmacology. 
2012; 37: 1923-33. 
Hollander E, Bartz J, Chaplin W, Phillips A, Sumner J, Soorya L, et al. Oxytocin increases retention of social 
cognition in autism. Biol Psychiatry. 2007; 61: 498-503. 
Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR, et al. Oxytocin infusion reduces 
repetitive behaviors in adults with autistic and Asperger's disorders. Neuropsychopharmacology. 
2003; 28: 193-8. 
Hollingshead A. Two factor index of social position.: Yale University, New Haven; 1957. 
Hsu M, Anen C, Quartz S. The right and the good: distributive justice and neural encoding of equity and 
efficiency. Science. 2008; 320: 1092-5. 
 38 
Hurlemann R, Patin A, Onur OA, Cohen MX, Baumgartner T, Metzler S, et al. Oxytocin enhances 
amygdala-dependent, socially reinforced learning and emotional empathy in humans. J Neurosci. 
2010; 30: 4999-5007. 
Inoue H, Yamasue H, Tochigi M, Abe O, Liu X, Kawamura Y, et al. Association between the oxytocin receptor 
gene and amygdalar volume in healthy adults. Biol Psychiatry. 2010; 68: 1066-72. 
Insel TR. The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative 
behavior. Neuron. 2010; 65: 768-79. 
Jin D, Liu H-X, Hirai H, Torashima T, Nagai T, Lopatina O, et al. CD38 is critical for social behaviour by 
regulating oxytocin secretion. Nature. 2007; 446: 41-5. 
Kaland N, Callesen K, Moller-Nielsen A, Mortensen EL, Smith L. Performance of children and adolescents 
with Asperger syndrome or high-functioning autism on advanced theory of mind tasks. J Autism 
Dev Disord. 2008; 38: 1112-23. 
Kana RK, Keller TA, Cherkassky VL, Minshew NJ, Just MA. Sentence comprehension in autism: thinking in 
pictures with decreased functional connectivity. Brain. 2006; 129: 2484-93. 
Kidd DC and Castano E. Reading literary fiction improves theory of mind. Science. 2013; 342: 377-80. 
Kim HS, Sherman DK, Sasaki JY, Xu J, Chu TQ, Ryu C, et al. Culture, distress, and oxytocin receptor 
polymorphism (OXTR) interact to influence emotional support seeking. Proc Natl Acad Sci USA. 
2010; 107: 15717-21. 
Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. Oxytocin increases trust in humans. Nature. 2005; 
435: 673-6. 
Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL, DiLavore PC, et al. The autism diagnostic observation 
 39 
schedule-generic: a standard measure of social and communication deficits associated with the 
spectrum of autism. J Autism Dev Disord. 2000; 30: 205-23. 
Lord C, Rutter M. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for 
caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 
1994; 24: 659-85. 
Masten CL, Colich NL, Rudie JD, Bookheimer SY, Eisenberger NI, Dapretto M. An fMRI investigation of 
responses to peer rejection in adolescents with autism spectrum disorders. Dev Cogn Neurosci. 
2011; 1: 260-70. 
Matsuoka K, Uno M, Kasai K, Koyama K, Kim Y. Estimation of premorbid IQ in individuals with Alzheimer's 
disease using Japanese ideographic script (Kanji) compound words: Japanese version of National 
Adult Reading Test. Psychiatry Clin Neurosci. 2006; 60: 332-9. 
Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. Oxytocin and vasopressin in the human brain: social 
neuropeptides for translational medicine. Nat Rev Neurosci. 2011; 12: 524-38. 
Miller G. Neuroscience. The promise and perils of oxytocin. Science. 2013; 339: 267-9. 
Nelson HE. National Adult Reading Test (NART). Windsor, UK: NFER-Nelson; 1982. 
Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971; 9: 
97-113. 
Ortony A, Clore G, Collins A. The cognitive structure of emotions. New York: Cambridge University Press; 
1990. 
Pelphrey KA, Carter EJ. Charting the typical and atypical development of the social brain. Dev Psychopathol. 
2008; 20: 1081-102. 
 40 
Pelphrey KA, Morris JP, McCarthy G, Labar KS. Perception of dynamic changes in facial affect and identity in 
autism. Soc Cogn Affect Neurosci. 2007; 2: 140-9. 
Pelphrey KA, Shultz S, Hudac CM, Vander Wyk BC. Research review: Constraining heterogeneity: the social 
brain and its development in autism spectrum disorder. J Child Psychol Psychiatry. 2011; 52: 
631-44. 
Politis M, Loane C, Wu K, O'Sullivan SS, Woodhead Z, Kiferle L, et al. Neural response to visual sexual cues 
in dopamine treatment-linked hypersexuality in Parkinson's disease. Brain. 2013; 136: 400-11. 
Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders--Autism and 
Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveill 
Summ 2012; 61: 1–19. 
Redcay E, Dodell-Feder D, Mavros PL, Kleiner M, Pearrow MJ, Triantafyllou C, et al. Atypical brain 
activation patterns during a face-to-face joint attention game in adults with autism spectrum disorder. 
Hum Brain Mapp. 2013; 34: 2511-23. 
Riem MM, Bakermans-Kranenburg MJ, Pieper S, Tops M, Boksem MA, Vermeiren RR, et al. Oxytocin 
modulates amygdala, insula, and inferior frontal gyrus responses to infant crying: a randomized 
controlled trial. Biol Psychiatry. 2011; 70: 291-7. 
Rilling JK, DeMarco AC, Hackett PD, Thompson R, Ditzen B, Patel R, et al. Effects of intranasal oxytocin and 
vasopressin on cooperative behavior and associated brain activity in men. 
Psychoneuroendocrinology. 2012; 37: 447-61. 
Rossion B, Caldara R, Seghier M, Schuller A, Lazeyras F, Mayer E. A network of occipito-temporal 
face-sensitive areas besides the right middle fusiform gyrus is necessary for normal face processing. 
 41 
Brain. 2003; 126: 2381-95. 
Saito Y, Suga M, Tochigi M, Abe O, Yahata N, Kawakubo Y, et al. Neural correlate of autistic-like traits and a 
common allele in the oxytocin receptor gene. Soc Cogn Affect Neurosci. 2013 online publication. 
Saxe R, Schulz LE, Jiang YV. Reading minds versus following rules: dissociating theory of mind and executive 
control in the brain. Soc Neurosci. 2006;1 :2 84-98. 
Schulte-Rüther M, Greimel E, Piefke M, Kamp-Becker I, Remschmidt H, Fink G, et al. Age-dependent 
changes in the neural substrates of empathy in autism spectrum disorder. Soc Cogn Affect Neurosci. 
2013 online publication. 
Senju A, Southgate V, White S, Frith U. Mindblind eyes: an absence of spontaneous theory of mind in Asperger 
syndrome. Science. 2009; 325: 883-5. 
Shahrestani S, Kemp A, Guastella A. The impact of a single administration of intranasal oxytocin on the 
recognition of basic emotions in humans: a meta-analysis. Neuropsychopharmacology. 2013; 38: 
1929-36. 
Shamay-Tsoory S, Tibi-Elhanany Y, Aharon-Peretz J. The green-eyed monster and malicious joy: the 
neuroanatomical bases of envy and gloating (schadenfreude). Brain. 2007; 130: 1663-78. 
Shamay-Tsoory SG. Recognition of 'fortune of others' emotions in Asperger syndrome and high functioning 
autism. J Autism Dev Disord. 2008; 38: 1451-61. 
Shamay-Tsoory SG, Aharon-Peretz J, Perry D. Two systems for empathy: a double dissociation between 
emotional and cognitive empathy in inferior frontal gyrus versus ventromedial prefrontal lesions. 
Brain. 2009; 132: 617-27. 
Shamay-Tsoory SG, Fischer M, Dvash J, Harari H, Perach-Bloom N, Levkovitz Y. Intranasal administration of 
 42 
oxytocin increases envy and schadenfreude (gloating). Biol Psychiatry. 2009; 66: 864-70. 
Singer T. The neuronal basis and ontogeny of empathy and mind reading: review of literature and implications 
for future research. Neurosci Biobehav Rev. 2006; 30: 855-63. 
Singer T, Snozzi R, Bird G, Petrovic P, Silani G, Heinrichs M, et al. Effects of oxytocin and prosocial behavior 
on brain responses to direct and vicariously experienced pain. Emotion. 2008; 8: 781-91. 
Sommer M, Dohnel K, Sodian B, Meinhardt J, Thoermer C, Hajak G. Neural correlates of true and false belief 
reasoning. Neuroimage. 2007; 35: 1378-84. 
Strathearn L, Fonagy P, Amico J, Montague PR. Adult attachment predicts maternal brain and oxytocin 
response to infant cues. Neuropsychopharmacology. 2009; 34: 2655-66. 
Striepens N, Scheele D, Kendrick KM, Becker B, Schafer L, Schwalba K, et al. Oxytocin facilitates protective 
responses to aversive social stimuli in males. Proc Natl Acad Sci USA. 2012; 109: 18144-9. 
Tachibana M, Kagitani-Shimono K, Mohri I, Yamamoto T, Sanefuji W, Nakamura A, et al. Long-term 
administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with 
autism spectrum disorders. J Child Adolesc Psychopharmacol. 2013; 23: 123-7. 
Tost H, Kolachana B, Verchinski BA, Bilek E, Goldman AL, Mattay VS, et al. Neurogenetic effects of OXTR 
rs2254298 in the extended limbic system of healthy Caucasian adults. Biol Psychiatry. 2011; 70: 
e37-9. 
Tsuchiya K, Matsumoto K, Yagi A, Inada N, Kuroda M, Inokuchi E, et al. Reliability and validity of the Autism 
Diagnostic Interview - Revised - Japanese Version. J Autism Dev Disord. 2012; 43: 643-62. 
van Dijk W, Ouwerkerk J, Goslinga S, Nieweg M, Gallucci M. When people fall from grace: reconsidering the 
role of envy in Schadenfreude. Emotion. 2006; 6: 156-60. 
 43 
Van IJzendoorn MH, Bakermans-Kranenburg MJ. A sniff of trust: Meta-analysis of the effects of intranasal 
oxytocin administration on face recognition, trust to in-group, and trust to out-group. 
Psychoneuroendocrinology. 2011; 37: 438-43. 
van Roekel E, Scholte RH, Didden R. Bullying among adolescents with autism spectrum disorders: prevalence 
and perception. J Autism Dev Disord. 2010; 40: 63-73. 
Veening JG, Olivier B. Intranasal administration of oxytocin: Behavioral and clinical effects, a review. 
Neurosci Biobehav Rev. 2013; 37: 1445-65. 
Völlm B, Taylor A, Richardson P, Corcoran R, Stirling J, McKie S, et al. Neuronal correlates of theory of mind 
and empathy: a functional magnetic resonance imaging study in a nonverbal task. Neuroimage. 
2006; 29: 90-8. 
Watanabe T, Abe O, Kuwabara H, Yahata N, Takano Y, Iwashiro N, et al. Mitigation of sociocommunicational 
deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized 
trial. JAMA Psychiatry. 2014; 71: 166-75. 
Watanabe T, Yahata N, Abe O, Kuwabara H, Inoue H, Takano Y, et al. Diminished medial prefrontal activity 
behind autistic social judgments of incongruent information. PLoS One. 2012; 7: e39561. 
Wechsler D. Wechsler Adult Intelligence Scale—Revised. New York: Harcourt Brace Jovanovich; 1981. 
Wittfoth-Schardt D, Grunding J, Wittfoth M, Lanfermann H, Heinrichs M, Domes G, et al. Oxytocin 
modulates neural reactivity to children's faces as a function of social salience. 
Neuropsychopharmacology. 2012; 37: 1799-807. 
Wymbs NF, Bassett DS, Mucha PJ, Porter MA, Grafton ST. Differential recruitment of the sensorimotor 
putamen and frontoparietal cortex during motor chunking in humans. Neuron. 2012; 74: 936-46. 
 44 
Yamasue H. Function and structure in social brain regions can link oxytocin-receptor genes with autistic social 
behavior. Brain Dev. 2013; 35: 111-8. 
Yamasue H, Suga M, Yahata N, Inoue H, Tochigi M, Abe O, et al. Reply to: Neurogenetic effects of OXTR 
rs2254298 in the extended limbic system of healthy Caucasian adults. Biol Psychiatry. 2011; 70: 
e41-e2. 
Yamasue H, Yee J, Hurlemann R, Rilling J, Chen F, Meyer-Lindenberg A, et al. Integrative approaches utilizing 
oxytocin to enhance prosocial behavior: from animal and human social behavior to autistic social 
dysfunction. J Neurosci. 2012; 32: 14109-17. 
Young LJ, Wang Z. The neurobiology of pair bonding. Nat Neurosci. 2004; 7: 1048-54. 
 
 
 
 
 
